Bliss GVS Pharma Ltd. (BLISSGVS-BE) Share Price Hits Fresh 52-Week High

Bliss GVS Pharma Ltd. Share Price rose 4.3% to Rs 568.9, touched a fresh 52-week high of Rs 569.95 and took market capitalisation to Rs 5,521 crore.

Bliss GVS Pharma Ltd. Share Price moved up to Rs 568.9 on 19 August 2026, up Rs 23.45 or 4.3% from the previous close of Rs 545.45, after the stock touched a fresh 52-week high of Rs 569.95. With the move, the company’s market capitalisation stood at Rs 5,521 crore, putting the stock among notable Healthcare names attracting attention in Stock Market Today screens for 52 Week High Stocks and Market Movers.

The supplied data confirms the price event clearly: Bliss GVS Pharma Ltd. opened at Rs 569.75, traded between Rs 551.05 and Rs 569.95, and recorded turnover of Rs 0.35 crore on volume of 6,118 shares. That intraday profile shows the stock opened close to its session peak and held near the top of the day’s range, which is often why a one-year high appears prominently in Share Market Today and Stocks in News scans.

For investors tracking Bliss GVS Pharma Ltd Share Price Today, the immediate relevance comes from three facts visible in the verified numbers. First, the stock registered a fresh yearly high. Second, the move came with a market value of Rs 5,521 crore, well above the Healthcare sector median market cap. Third, valuation and return ratios show a mixed Fundamental Analysis picture, which makes the stock worth watching even though the supplied data does not establish any company-specific catalyst. At Univest, that combination of price action, valuation and sector context is what turns a simple high into a useful stock analysis discussion.

Bliss GVS Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 568.9
Previous Close	Rs 545.45
Today's Change	+Rs 23.45 (+4.3%)
Day Open	Rs 569.75
Fresh 52-Week High	Rs 569.95
Day Low	Rs 551.05
Current Volume	6,118
Turnover	Rs 0.35 crore
Market Capitalisation	Rs 5,521 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 568.9. versus the previous close of Rs 545.45, a rise of 4.3%. The stock opened at Rs 569.75, reached Rs 569.95, touched Rs 551.05. Reported volume was 6,118.

Bliss GVS Pharma Ltd. Share Price Today shows a clear breakout session in price terms, with the stock rising 4.3% from Rs 545.45 to Rs 568.9 and touching a fresh 52-week peak of Rs 569.95. The stock opened at Rs 569.75, slipped to an intraday low of Rs 551.05, and then stayed close to the day’s upper band, highlighting strong attention in early trade.

What exactly happened today is straightforward from the verified data. Bliss GVS Pharma Ltd Share Price opened above the previous close and quickly moved to Rs 569.95, which marked the new one-year high. The closing reference available in the dataset is the last traded price of Rs 568.9, leaving the stock only Rs 1.05 above the previous close short of its intraday high for most of the session snapshot. That indicates the day’s gain was largely retained rather than fully reversed intraday.

The stock’s trading band of Rs 551.05 to Rs 569.95 gives an intraday range of Rs 18.90. Against a previous close of Rs 545.45, even the session low remained above the prior day’s closing level by Rs 5.60, while the day high was Rs 24.50 higher. Turnover stood at Rs 0.35 crore with volume of 6,118 shares. In pure Price Action terms, that keeps Bliss GVS Pharma Ltd Stock News relevant because the market is seeing a stock print a fresh 52 Week High while preserving most of the day’s gain.

For readers searching Bliss GVS Pharma Ltd Share Price Live or Bliss GVS Pharma Ltd News Today, the key takeaway is that the supplied data confirms the breakout event itself, but not a separate company-specific trigger. That shifts the next layer of analysis toward fundamentals, valuation and relative sector standing, which is where Univest sees whether the latest Share Price Update is supported by broader context.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,521 crore
P/E Ratio	51.17x
P/B Ratio	2.03x
ROE	-0.78%
ROCE	8.31%

Bliss GVS Pharma Ltd. was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	51.17x
Benchmark Median P/E	20.79x
Benchmark Average P/E	47.16x
Benchmark P/E Range	0x to 1,635.98x
Company P/B Ratio	2.03x
Benchmark Median P/B	1.9x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 5,521 crore
Benchmark Median Market Cap	Rs 134.22 crore

Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,724.51	51.17	2.03	-0.78	8.31
Beta Drugs Ltd.	BETA	2,697.08	62.93	9.96	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,583.65	33.9	6.99	36.29	42.4
Sai Parenteral's Ltd.	SAIPARENT	2,431.62	167.79	3.07	13.9	12.97
Fredun Pharmaceuticals Ltd.	FREDUN	2,403.56	54.45	8.13	11.42	13.15

Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 5,521 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Bliss GVS Pharma Ltd.

The stock is attracting attention because several verified factors have converged in one session.

• Fresh 52-week high: Bliss GVS Pharma Ltd Share Price touched Rs 569.95 and traded at Rs 568.9, up 4.3% on the day.
• Strong session positioning: The stock opened at Rs 569.75 and remained close to the day’s high after trading between Rs 551.05 and Rs 569.95.
• Meaningful scale: Market capitalisation stands at Rs 5,521 crore, well above the same-sector median of Rs 134.22 crore and average of Rs 465.93 crore.
• Mixed valuation backdrop: P/E of 51.17 is above the Healthcare median of 20.79, while P/B of 2.03 is near the sector median of 1.9.
• Return ratios lag benchmarks: ROE of -0.78% and ROCE of 8.31% are below the Healthcare median levels of 11.09% and 13.29%.
• Peer contrast: The company is larger than the supplied peers by market cap, but several peers show stronger ROE and ROCE figures.

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. (BLISSGVS-BE) is represented in the supplied market dataset as a Healthcare company. The peer set places most comparable names within Pharmaceuticals & Drugs, while one comparable company is classified under Hospital & Healthcare Services, indicating that the stock is being assessed in a broad Healthcare market context.

For investors reading Bliss GVS Pharma Ltd Latest News or Bliss GVS Pharma Ltd Company News, the practical takeaway is that the stock is currently being evaluated by the market through sector valuation, return ratios and market-cap positioning rather than through a detailed business description in the supplied data. The company’s Rs 5,521 crore market capitalisation makes it larger than the listed peer companies included here, which helps explain why its Share Price Update can attract attention across NSE and BSE-oriented market screens. On Univest, that makes Bliss GVS Pharma Ltd a name to track through price levels, valuation shifts and peer comparisons as new verified company data emerges.

Track Bliss GVS Pharma Ltd. Share Price on Univest

Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors following Bliss GVS Pharma Ltd Share Price can use Univest to track live share price moves, 52-week levels, market capitalisation, valuation ratios, sector comparisons and peer positioning in one place. Univest also helps users monitor Share Price changes across NSE and BSE market coverage, alongside stock analysis tools that place daily moves in a broader financial context.

For readers searching Bliss GVS Pharma Ltd Share Price Today, Bliss GVS Pharma Ltd Stock News or Bliss GVS Pharma Ltd Market Cap, tracking the stock on Univest can help connect one-day price action with fundamentals such as P/E, P/B, ROE and ROCE. That is especially useful when a stock reaches a fresh one-year high and investors want a structured view of price, sector and peer data without jumping to conclusions from a single session.

Frequently Asked Questions

What is the latest Bliss GVS Pharma Ltd Share Price Today?

Ans. Bliss GVS Pharma Ltd Share Price Today was Rs 568.9 in the supplied market snapshot. The stock was up Rs 23.45, or 4.3%, from the previous close of Rs 545.45 during the 19 August 2026 session.

Did Bliss GVS Pharma Ltd hit a fresh 52-week high today?

Ans. Yes, the stock touched a fresh 52-week high of Rs 569.95. That made Bliss GVS Pharma Ltd one of the Healthcare names drawing attention in market screens tracking yearly highs and notable intraday price action.

Why is Bliss GVS Pharma Ltd rising today?

Ans. The supplied data confirms that Bliss GVS Pharma Ltd rose 4.3% and reached a new 52-week peak, but it does not establish a company-specific trigger. The verified facts are the price move, the one-year high and the session range.

What were the day’s open, high and low levels for Bliss GVS Pharma Ltd?

Ans. The stock opened at Rs 569.75, touched a high of Rs 569.95 and a low of Rs 551.05. That kept trading concentrated near the upper end of the day’s range for most of the supplied snapshot.

How much market capitalisation does Bliss GVS Pharma Ltd have?

Ans. Bliss GVS Pharma Ltd had a market capitalisation of Rs 5,521 crore in the supplied data. That is significantly above the Healthcare sector median of Rs 134.22 crore and the sector average of Rs 465.93 crore.

Is Bliss GVS Pharma Ltd expensive compared with the Healthcare sector?

Ans. On earnings, the stock looks higher than the sector median because its P/E is 51.17 versus the Healthcare median of 20.79 and average of 47.16. Its P/B of 2.03 is only slightly above the median of 1.9.

How do the company’s return ratios compare with the sector?

Ans. The company’s ROE is -0.78% and ROCE is 8.31%. Both are below the Healthcare sector median readings of 11.09% for ROE and 13.29% for ROCE in the supplied same-sector benchmark.

How does Bliss GVS Pharma Ltd compare with its listed peers?

Ans. The company’s market cap of Rs 5,521 crore is larger than the supplied peers, but profitability is weaker. Several peers, including Beta Drugs and Dr Agarwals Eye Hospital, show higher ROE and ROCE than Bliss GVS Pharma Ltd.

What trading activity was recorded in Bliss GVS Pharma Ltd today?

Ans. The supplied data shows volume of 6,118 shares and turnover of Rs 0.35 crore. Those figures confirm active participation during the breakout session, even though the dataset does not provide average volume or delivery metrics.

What should investors monitor next in Bliss GVS Pharma Ltd Stock News?

Ans. Investors can monitor whether Bliss GVS Pharma Ltd sustains levels near its fresh 52-week high, while also tracking valuation against the Healthcare benchmark and watching whether return metrics such as ROE and ROCE improve over time.